Quantinno Capital Management LP Buys 2,373 Shares of Mettler-Toledo International, Inc. $MTD

Quantinno Capital Management LP raised its position in Mettler-Toledo International, Inc. (NYSE:MTD) by 12.3% during the first quarter, according to its most recent filing with the SEC. The firm owned 21,708 shares of the medical instruments supplier’s stock after purchasing an additional 2,373 shares during the period. Quantinno Capital Management LP’s holdings in Mettler-Toledo International were worth $27,379,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Reflection Asset Management bought a new stake in Mettler-Toledo International during the fourth quarter valued at $26,000. Whipplewood Advisors LLC acquired a new position in shares of Mettler-Toledo International in the 1st quarter valued at about $25,000. Elyxium Wealth LLC acquired a new position in shares of Mettler-Toledo International in the 4th quarter valued at about $29,000. DV Equities LLC bought a new stake in shares of Mettler-Toledo International during the 4th quarter valued at about $40,000. Finally, Root Financial Partners LLC boosted its position in shares of Mettler-Toledo International by 45.5% during the 1st quarter. Root Financial Partners LLC now owns 32 shares of the medical instruments supplier’s stock valued at $40,000 after purchasing an additional 10 shares in the last quarter. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International News Roundup

Here are the key news stories impacting Mettler-Toledo International this week:

• Positive Sentiment: Quarterly earnings beat expectations: Adjusted EPS rose 14% year over year to $11.46, exceeding the $10.80 consensus estimate by $0.66. Revenue increased approximately 4% to $1.03 billion, in line with expectations, while reported EPS reached $11.55 versus $9.76 a year earlier. Mettler-Toledo Second-Quarter 2026 Results
• Positive Sentiment: Full-year outlook was raised: Mettler-Toledo now expects fiscal 2026 EPS of $47.15 to $47.50, above the prior consensus estimate of $46.64. The updated outlook supports expectations for continued earnings growth and helped strengthen the investment case. Mettler-Toledo Second-Quarter 2026 Results
• Positive Sentiment: Jefferies became more bullish: Jefferies Financial Group raised its price target from $1,400 to $1,580 and upgraded the stock to “buy,” implying roughly 11% upside from the referenced trading level. The upgrade provides additional positive analyst momentum. Benzinga analyst-upgrade report
• Neutral Sentiment: Third-quarter guidance was broadly in line: EPS guidance of $12.00 to $12.15 brackets the $12.12 consensus estimate, while revenue guidance of approximately $1.1 billion is consistent with expectations. This suggests steady performance but provides less of a near-term upside surprise than the full-year outlook.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,418.55 on Friday. Mettler-Toledo International, Inc. has a one year low of $1,023.05 and a one year high of $1,525.17. The firm has a market capitalization of $28.67 billion, a price-to-earnings ratio of 31.93, a PEG ratio of 2.88 and a beta of 1.24. The business has a 50-day simple moving average of $1,237.30 and a 200 day simple moving average of $1,276.04.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $11.46 earnings per share for the quarter, topping analysts’ consensus estimates of $10.80 by $0.66. The business had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.03 billion. Mettler-Toledo International had a negative return on equity of 872.07% and a net margin of 21.91%.The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the business earned $10.09 EPS. Mettler-Toledo International has set its FY 2026 guidance at 47.150-47.500 EPS and its Q3 2026 guidance at 12.000-12.150 EPS. On average, sell-side analysts expect that Mettler-Toledo International, Inc. will post 46.63 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on MTD. Stifel Nicolaus lowered their target price on Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating for the company in a report on Monday, May 18th. JPMorgan Chase & Co. cut their price target on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Weiss Ratings downgraded shares of Mettler-Toledo International from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, July 21st. Jefferies Financial Group lifted their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the company a “buy” rating in a research note on Friday. Finally, Wall Street Zen downgraded shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and an average target price of $1,420.36.

Mettler-Toledo International Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.